Biomarker and Genetic Predictors of Erenumab Treatment Response

NCT04265755 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1406
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen